Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D287006-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $146.90 | |
D287006-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $582.90 |
MT2receptor antagonist
Synonyms | DH 97|DH97|220339-00-4|343263-95-6|N-[2-(2-benzyl-1H-indol-3-yl)ethyl]pentanamide|N-(2-(2-Benzyl-1H-indol-3-yl)ethyl)pentanamide|Luzindole,N-pentanoyl|Tocris-1218|N-pentanoyl 2-benzyltryptamine|N-Pentanoyl-2-benzyltryptamine|GTPL3366|SCHEMBL1626901|CHEMBL |
---|---|
Specifications & Purity | Moligand™ |
Biochemical and Physiological Mechanisms | A relatively potent MT2melatonin receptor antagonist (pKivalue = 8.03), displaying 89- and 229-fold selectivity over MT1and GPR50 (melatonin-related orphan receptor) respectively. |
Storage Temp | Room temperature |
Shipped In | Normal |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of MT 2 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-[2-(2-benzyl-1H-indol-3-yl)ethyl]pentanamide |
---|---|
INCHI | InChI=1S/C22H26N2O/c1-2-3-13-22(25)23-15-14-19-18-11-7-8-12-20(18)24-21(19)16-17-9-5-4-6-10-17/h4-12,24H,2-3,13-16H2,1H3,(H,23,25) |
InChi Key | HDOIPCLEKCEANF-UHFFFAOYSA-N |
Canonical SMILES | CCCCC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 |
Isomeric SMILES | CCCCC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 |
PubChem CID | 3467177 |
Molecular Weight | 334.46 |
Enter Lot Number to search for COA:
Solubility | Solvent:DMSO, Max Conc. mg/mL: None, Max Conc. mM: 100 |
---|